Cargando…
Structure-function analyses of candidate small molecule RPN13 inhibitors with antitumor properties
We sought to design ubiquitin-proteasome system inhibitors active against solid cancers by targeting ubiquitin receptor RPN13 within the proteasome’s 19S regulatory particle. The prototypic bis-benzylidine piperidone-based inhibitor RA190 is a michael acceptor that adducts Cysteine 88 of RPN13. In p...
Autores principales: | Anchoori, Ravi K., Tan, Marietta, Tseng, Ssu-Hsueh, Peng, Shiwen, Soong, Ruey-Shyang, Algethami, Aliyah, Foran, Palmer, Das, Samarjit, Wang, Chenguang, Wang, Tian-Li, Liang, Hong, Hung, Chien-Fu, Roden, Richard B. S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6961910/ https://www.ncbi.nlm.nih.gov/pubmed/31940398 http://dx.doi.org/10.1371/journal.pone.0227727 |
Ejemplares similares
-
RPN13/ADRM1 inhibitor reverses immunosuppression by myeloid-derived suppressor cells
por: Soong, Ruey-Shyang, et al.
Publicado: (2016) -
Covalent Rpn13-Binding Inhibitors for
the Treatment of Ovarian Cancer
por: Anchoori, Ravi K., et al.
Publicado: (2018) -
Chirality and asymmetry increase the potency of candidate ADRM1/RPN13 inhibitors
por: Anchoori, Ravi K., et al.
Publicado: (2021) -
Development and anticancer properties of Up284, a spirocyclic candidate ADRM1/RPN13 inhibitor
por: Anchoori, Ravi K., et al.
Publicado: (2023) -
Bis-benzylidine Piperidone RA190 treatment of hepatocellular carcinoma via binding RPN13 and inhibiting NF-κB signaling
por: Soong, Ruey-Shyang, et al.
Publicado: (2020)